The British Pharmacopoeia 2026 (BP 2026) is the UK’s legally enforceable compendium of pharmaceutical standards, essential for ensuring compliance in medicine development, manufacture, and testing. Effective from 1 January 2026, BP 2026 replaces BP 2025.
What’s new in BP 2026
19 new monographs added to BP 2026, with 34 monographs updated from Ph. Eur. 11.6–11.8
131 existing monographs revised to reflect the latest scientific, regulatory, and quality standards
Two new appendices, four supplementary chapters, and six new infrared reference spectra for enhanced technical guidance
!!<Why BP 2026 matters
The British Pharmacopoeia is the only government-sanctioned pharmaceutical compendium in the UK, carrying full legal authority under the Human Medicines Regulations. BP 2026 ensures that all pharmaceutical substances and product.